Litcius/Paper detail

microRNA-324-3p suppresses the aggressive ovarian cancer by targeting <i>WNK2</i>/RAS pathway

Fengjie Li, Zhen Liang, Yongqin Jia, Panyang Zhang, Kaijian Ling, Yanzhou Wang, Zhiqing Liang

2022Bioengineered13 citationsDOIOpen Access PDF

Abstract

/RAS pathway. Our study provides theoretical evidence for the clinical application potential of miR-324-3p.

Topics & Concepts

microRNACell growthOvarian cancerCancer researchBiologyBlotDownregulation and upregulationCellLuciferaseReporter geneTransfectionMolecular biologyCell cultureCancerGene expressionGeneBiochemistryGeneticsMicroRNA in disease regulationCircular RNAs in diseasesCancer Mechanisms and Therapy
microRNA-324-3p suppresses the aggressive ovarian cancer by targeting <i>WNK2</i>/RAS pathway | Litcius